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A 5-L bioreactor reduced scale model (RSM) was qualified for 2000-L manufacturing scale for a CHO cell line 
producing a recombinant monoclonal antibody. The study identified process performance and product quality 
attributes that capture important aspects of the production bioreactor process. The qualification of the smaller 
scale bioreactors – showing that the attributes are comparable across scales – was performed using two novel 
statistical approaches: multivariate dimension reduction and data visualization techniques, via PLS-DA, and 
Bayesian multivariate linear modeling for inferential analysis. Bayesian linear modeling results comparing 
individual probability distributions of the differences and ratios of the mean of each attribute for each scale, as 
well as joint probability statements on the differences and ratios of the means for multiple attributes, are 
presented. After analysis by PLS-DA, adjustments to the operating conditions of the 5-L bioreactors were 
identified so that performance more closely resembles that of the 2000-L manufacturing scale. The results of the 
analyses facilitate iterative and risk-based decision making with regards to the continuous improvement of the 
reduced scale bioreactor models. Using Bayesian Multivariate Linear Modeling to assess equivalence between 
scales and PLS-DA to determine potential improvements to the RSM allows for a continuous and iterative 
approach to RSM qualification and model improvement. 
 
 
